GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoTherapy Science Inc (TSE:4564) » Definitions » Deferred Policy Acquisition Costs

OncoTherapy Science (TSE:4564) Deferred Policy Acquisition Costs


View and export this data going back to 2003. Start your Free Trial

What is OncoTherapy Science Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


OncoTherapy Science Business Description

Industry
Traded in Other Exchanges
Address
11th Floor, Kanagawa Science Park R&D, 3-2-1 Sakado, Kanagawa, Kawasaki, JPN, 213-0012
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.